Figma Inc. Class A Common Stock vs Tilray Brands Inc — how do they compare? Figma Inc. Class A Common Stock trades at $21.23 (market cap $11.60B), while Tilray Brands Inc trades at $3.11 (market cap $481.79M). The key difference: Figma Inc. Class A Common Stock is far larger — about 24.1× Tilray Brands Inc's market cap, and Figma Inc. Class A Common Stock is more actively traded (12,281,013 versus 4,056,443). Which is the better fit depends on your goals — on Pluang, investors hold Figma Inc. Class A Common Stock for 0 Days and Tilray Brands Inc for 31 Days on average.
| FIG | TLRY | |
|---|---|---|
Market Cap | $11.60B | $481.79M |
Volume | 12,281,013 | 4,056,443 |
Sector | Technology | Health |
52-Week High | $63.82 | $16.80 |
52-Week Low | $16.84 | $3.14 |
Typical Hold Time | 0 Days | 31 Days |
Enterprise Value | $10.00B | $635.71M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Tilray Brands (TLRY) trades at $3.27, down 2.68% on the day and near 52-week lows, with bearish technical signals dominating. The company reported $821 million in revenue for 2025 but posted a massive $2.19 billion net loss due to impairment charges. Recent earnings misses and negative cash flow from operations highlight ongoing profitability challenges despite analyst consensus pointing to significant upside potential.
TLRY presents a high-risk opportunity with substantial analyst price target divergence. While valuation metrics appear attractive (P/S 0.4x, P/B 0.3x), persistent losses and cash burn require careful monitoring. The stock's fate hinges on cannabis reform progress and the company's ability to achieve sustainable profitability amid competitive pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Figma, Inc. is a US software company that operates a collaborative interface design and product development platform used by design and engineering teams to create, prototype, and build digital products.
Read more on FIG →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →